Congenital hypothyroidism in Bogotá, Colombia: a current description (2015-2021).
congenital abnormalities
congenital hypothyroidism
congenital hypothyroidism screening
newborn screening
prevalence
public health surveillance
Journal
Journal of pediatric endocrinology & metabolism : JPEM
ISSN: 2191-0251
Titre abrégé: J Pediatr Endocrinol Metab
Pays: Germany
ID NLM: 9508900
Informations de publication
Date de publication:
28 Aug 2023
28 Aug 2023
Historique:
received:
06
04
2023
accepted:
30
06
2023
medline:
10
8
2023
pubmed:
20
7
2023
entrez:
20
7
2023
Statut:
epublish
Résumé
Congenital hypothyroidism (CH) is a decrease in thyroid hormone function in newborns, being one of the leading causes of neurological deficits and long-term metabolic complications. This study aims to determine the prevalence and characteristics of CH cases in Bogotá, Colombia, between 2015 and 2021, as notified through the mandatory report to the Public Health Surveillance System (PHSS). A retrospective cross-sectional study was conducted. All live births (LB) with a weight ≥500 g, diagnosed with CH with or without goiter (ICD-10 codes E030 and E031, respectively) in Bogotá during 2015-2021 were analyzed. For a total of 201 cases, the prevalence rate was 3.29 cases per 10,000 LB. 92.54 % were classified as isolated cases of CH, 4.48 % syndromic, and 2.98 % polymalformated. A total of 16.92 % was small for gestational age. The mean gestational age was 37.38 weeks (SD 2.76), 26.87 % were preterm births. Among the mothers, 8.96 % suffered from pregnancy-related or chronic diseases, the most common being hypertensive disorders of pregnancy and pre-existant hypothyroidism (without clarity concerning etiology). A total of 66.67 % of cases did not receive treatment after diagnosis. Treatment was established by an average age of 27 days after birth (SD 36.02) and 17 days after case notification to the PHSS (SD 36.13). Observed prevalence is similar to the rate reported by health authorities in Colombia but inferior to reports from high-income countries, highlighting the importance of improvements in the Colombian LB's screening program. Time to diagnosis and treatment was observed to be prolonged, suggesting that new pathways are required for timely CH treatment.
Identifiants
pubmed: 37469167
pii: jpem-2023-0150
doi: 10.1515/jpem-2023-0150
doi:
Substances chimiques
Thyrotropin
9002-71-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
772-776Informations de copyright
© 2023 Walter de Gruyter GmbH, Berlin/Boston.
Références
Hinton, CF, Harris, KB, Borgfeld, L, Drummond-Borg, M, Eaton, R, Lorey, F, et al.. Trends in incidence rates of congenital hypothyroidism related to select demographic factors: data from the United States, California, Massachusetts, New York, and Texas. Pediatrics 2010;125(2 Suppl):S37–47. https://doi.org/10.1542/peds.2009-1975d .
doi: 10.1542/peds.2009-1975d
Ford, G, LaFranchi, SH. Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pract Res Clin Endocrinol Metabol 2014;28:175–87. https://doi.org/10.1016/j.beem.2013.05.008 .
doi: 10.1016/j.beem.2013.05.008
Ospina Martínez, ML, Prieto Alvarado, FE. Congenital defects report . Bogotá, Colombia: Colombian National Institute of Health; 2021:21 p.
Ojeda Rincon, SA, Gualdron Rincon, EF, Garcia Rueda, NA, Sarmiento Villamizar, DF, Parada Botello, NS, Gelves Diaz, SA, et al.. Congenital hypothyroidism, the first cause of preventable mental retardation: a challenge for preventive medicine. Rev Médicas UIS. 2016;29:53–60. https://doi.org/10.18273/revmed.v29n1-2016006 .
doi: 10.18273/revmed.v29n1-2016006
Chan, SY, Vasilopoulou, E, Kilby, MD. The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metabol 2009;5:45–54. https://doi.org/10.1038/ncpendmet1026 .
doi: 10.1038/ncpendmet1026
Rastogi, MV, LaFranchi, SH. Congenital hypothyroidism. Orphanet J Rare Dis 2010;5:17. https://doi.org/10.1186/1750-1172-5-17 .
doi: 10.1186/1750-1172-5-17
Colombian National Institute of Health . Congenital defects surveillance protocol. Non-communicable diseases surveillance and control group. [Internet]; 2023. Jan [cited 2023 Jun 11]. Available from: https://www.ins.gov.co/buscador-eventos/SitePages/Evento.aspx?Event=18] .
LaFranchi, SH, Rastogi, MV. Orphanet: congenital hypothyroidism [Internet]; 2010. [cited 2022 Nov 7]. Available from: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=442 .
Hinojosa Trejo, MA, Vela Amieva, M, Ibarra González, I, De Cosío Farias, AP, del Herrera Pérez, LA, Caamal Parra, G, et al.. Birth prevalence of congenital hypothyroidism. Acta Pediátrica México 2018;39:5. https://doi.org/10.18233/apm39no6pp5s-13s1717 .
doi: 10.18233/apm39no6pp5s-13s1717
van Trotsenburg, P, Stoupa, A, Léger, J, Rohrer, T, Peters, C, Fugazzola, L, et al.. Congenital hypothyroidism: a 2020–2021 consensus guidelines update—an ENDO-European reference network initiative endorsed by the European society for pediatric endocrinology and the European society for endocrinology. Thyroid 2021;31:387–419. https://doi.org/10.1089/thy.2020.0333 .
doi: 10.1089/thy.2020.0333
Albert, BB, Cutfield, WS, Webster, D, Carll, J, Derraik, JGB, Jefferies, C, et al.. Etiology of increasing incidence of congenital hypothyroidism in New Zealand from 1993–2010. J Clin Endocrinol Metab 2012;97:3155–60. https://doi.org/10.1210/jc.2012-1562 .
doi: 10.1210/jc.2012-1562
Peñaloza, L, Forero, C, Céspedes, C. Characterization of patients with congenital hypothyroidism in hospital universitario san Ignacio between 2001 and 2017. Biomedica 2020;40:528–33. https://doi.org/10.7705/biomedica.5334 .
doi: 10.7705/biomedica.5334
Boileau, P, Bain, P, Rives, S, Toublanc, JE. Earlier onset of treatment or Increment in LT4 dose in screened congenital hypothyroidism: which was the more important factor for IQ at 7 Years? Horm Res Paediatr 2004;61:228–33. https://doi.org/10.1159/000076597 .
doi: 10.1159/000076597
Rahmani, K, Yarahmadi, S, Etemad, K, Koosha, A, Mehrabi, Y, Aghang, N, et al.. Congenital hypothyroidism: optimal initial dosage and time of initiation of treatment: a systematic review. Int J Endocrinol Metab 2016;14:e36080. https://doi.org/10.5812/ijem.36080 .
doi: 10.5812/ijem.36080
Multicenter Study Collaborative Group for Evaluation of Outcomes in Very Low Birth Weight Infants . [Perinatal risk factors for congenital hypothyroidism in very preterm infants: a multicenter prospective study]. Zhonghua Er Ke Za Zhi Chin J Pediatr 2022;60:545–50.
Sardana, G, Malwade, S, Agarkhedkar, S. Prevalence and risk factors associated with elevated thyroid stimulating hormone in late preterm newborns with low birthweight: a cross-sectional study. J Neonatol 2022;36:173–6. https://doi.org/10.1177/09732179221100504 .
doi: 10.1177/09732179221100504
Herrera-Chinchay, L, Silva-Ocas, I, Castro-Silva, N, Del Águila Villar, C. Social, cognitive and psicomotor development in peruvian children with congenital hypothyroidism. Andes Pediatr 2021;92:235. https://doi.org/10.32641/andespediatr.v92i2.1955 .
doi: 10.32641/andespediatr.v92i2.1955
Huo, K, Zhang, Z, Zhao, D, Li, H, Wang, J, Wang, X, et al.. Risk factors for neurodevelopmental deficits in congenital hypothyroidism after early substitution treatment. Endocr J 2011;58:355–61. https://doi.org/10.1507/endocrj.k10e-384 .
doi: 10.1507/endocrj.k10e-384
Bran Piedrahita, L, Valencia Arias, A, Palacios Moya, L, Gómez Molina, S, Acevedo Correa, Y, Arias Arciniegas, C, et al.. Access barriers to healthcare system in Colombian rural areas: subsidiary regime user perceptions. Hacia Promoc Salud 2020;25:29–38. https://doi.org/10.17151/hpsal.2020.25.2.6 .
doi: 10.17151/hpsal.2020.25.2.6